Risk assessment of readmissions following an initial COPD-related hospitalization

Christine L Baker,1 Kelly H Zou,1 Jun Su2 1Pfizer Inc, New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA Background: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a leading cause of hospitalizations and readmissions in the US. Reducing the freq...

Full description

Bibliographic Details
Main Authors: Baker CL, Zou KH, Su J
Format: Article
Language:English
Published: Dove Medical Press 2013-11-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/risk-assessment-of-readmissions-following-an-initial-copd-related-hosp-a14965

Similar Items